Dassault Systemes targets life sciences with $5.8 billion Medidata deal | Reuters

null
France’s Dassault Systemes moved to build up its life sciences presence with a $5.8 billion cash deal to buy Medidata Solutions, a U.S. firm focused on clinical trials.

Dassault Systemes has been doing deals to diversify its technology and software businesses further and its agreed acquisition of Medidata, its largest, follows its purchases of companies including Trace Software and Argosim.

Medidata has a market capitalization of around $5.9 billion, Refinitiv Eikon data shows, while Dassault has a stock market value of around 36 billion euros ($41 billion).

Source: Dassault Systemes targets life sciences with $5.8 billion Medidata deal – Reuters

READ  How regulators can discourage a repeat of United’s overbooking fiasco | Vox

Leave a Reply

Your email address will not be published. Required fields are marked *